These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35234559)

  • 21. Home Therapies in Advanced Heart Failure: Inotropes and Diuretics.
    Graffagnino JP; Avant LC; Calkins BC; Swetz KM
    Curr Heart Fail Rep; 2020 Oct; 17(5):314-323. PubMed ID: 32830304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
    Siostrzonek P; Koreny M; Delle-Karth G; Haumer M; Koller-Strametz J; Heinz G
    Acta Anaesthesiol Scand; 2000 Apr; 44(4):403-9. PubMed ID: 10757572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
    Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
    Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Milrinone in advanced heart failure: dose and therapeutic monitor outside intensive care unit.
    Charisopoulou D; Leaver N; Banner NR
    Angiology; 2014 Apr; 65(4):343-9. PubMed ID: 23620310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palliative care in heart failure.
    Wiskar K; Toma M; Rush B
    Trends Cardiovasc Med; 2018 Oct; 28(7):445-450. PubMed ID: 29735287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.
    Lee EC; McNitt S; Martens J; Bruckel JT; Chen L; Alexis JD; Storozynsky E; Thomas S; Gosev I; Barrus B; Goldenberg I; Vidula H
    Int J Cardiol; 2020 Aug; 313():83-88. PubMed ID: 32320777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palliative care and hospice in advanced heart failure.
    Lemond L; Allen LA
    Prog Cardiovasc Dis; 2011; 54(2):168-78. PubMed ID: 21875515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?
    Grubb CS; Truby LK; Topkara VK; Bohnen MS; Yuzefpolskaya M; DeFilippis EM; Kleet A; Nakagawa S; Haythe JH; Axsom K; Colombo P; Takeda K; Uriel N; Sayer G; Garan H; Naka Y; Farr M
    Am Heart J; 2021 Sep; 239():11-18. PubMed ID: 33984317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "I Just Feel Like I Always Did": Inotropic Dependency at End of Life.
    Latimer A; Pope ND; McFarlin JM
    Am J Hosp Palliat Care; 2020 Jul; 37(7):497-502. PubMed ID: 31714150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
    Cesario D; Clark J; Maisel A
    Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to advanced heart failure at the end of life.
    Steinberg L; White M; Arvanitis J; Husain A; Mak S
    Can Fam Physician; 2017 Sep; 63(9):674-680. PubMed ID: 28904030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart Failure: A Palliative Medicine Review of Disease, Therapies, and Medications With a Focus on Symptoms, Function, and Quality of Life.
    McGuinty C; Leong D; Weiss A; MacIver J; Kaya E; Hurlburt L; Billia F; Ross H; Wentlandt K
    J Pain Symptom Manage; 2020 May; 59(5):1127-1146.e1. PubMed ID: 31866489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palliative Care in Patients with Advanced Heart Failure.
    Kida K; Doi S; Suzuki N
    Heart Fail Clin; 2020 Apr; 16(2):243-254. PubMed ID: 32143768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 1999 Jun; 39(6):643-8. PubMed ID: 10502990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended Release Oral Milrinone, CRD-102, for Advanced Heart Failure.
    Nanayakkara S; Mak V; Crannitch K; Byrne M; Kaye DM
    Am J Cardiol; 2018 Sep; 122(6):1017-1020. PubMed ID: 30064857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
    King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
    Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart Failure: Advanced Refractory Heart Failure.
    Rose-Jones LJ
    FP Essent; 2021 Jul; 506():31-42. PubMed ID: 34264591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.